Opinion
Video
Evolution of Oncology Pharmacy Practice in mCRC
Experts discuss how the role of oncology pharmacists in managing metastatic colorectal cancer (mCRC) has evolved, particularly in enabling medication adjustments, refills, and prescribing supportive care medications, and explore the impact of this expanded role on patient outcomes and how pharmacists can leverage medication knowledge to optimize treatment and patient care further.
Video Player is loading.
Video content above is prompted by the following:
- How has the role of oncology pharmacists in managing mCRC evolved, particularly in enabling medication adjustments, refills, and prescribing supportive care medications?
- What impact has this expanded role had on patient outcomes?
- In what ways can pharmacists leverage medication knowledge to optimize treatment and patient care for mCRC further?
Related Videos
The Patient Journey: Mapping the Pharmacist’s Role in mCRC Management
Exploring Social Determinants of Health in Uncomplicated UTIs
Trends in Uncomplicated UTIs
Care Pathways for Nonspecialist Providers When Evaluating Patients With Potential Mild Cognitive Impairment
Advancing Early Alzheimer Diagnosis: Best Practices for Timely Screening and Detection
CGM's Impact on Clinical Inertia
Key Benefits of CGM Technology
Optimizing Bispecific Antibody Use: Opportunities to Broaden Patient Access
Future Directions and Overcoming Challenges in BTK Inhibitor Therapy
Navigating HS Management: The Patient Journey
Related Content
